Telehealth

AI summary is being generated. Check back soon for a plain-language breakdown of this bill.

TN SB2580 is a senate bill in the Tennessee 114th General Assembly, sponsored by Robert Harshbarger (R), currently “Introduced” since February 2, 2026.

We track 9,160 Tennessee bills this session, 53 of them sponsored by Robert Harshbarger.

Positive media analysis is being generated.

Critical media analysis is being generated.

Senator Robert Harshbarger, as a pharmacist and owner of Harshbarger Pharmacy, has personal financial interests that align closely with the subject matter of SB2580, which pertains to telehealth and prescription medications. The bill aims to study the requirements for obtaining prescription medications via telehealth, which could directly impact the operations of pharmacies and the way pharmacists issue prescriptions. Given that Harshbarger is actively involved in the pharmaceutical industry, there is a potential for personal financial gain from any legislative changes that may ease restrictions on telehealth prescriptions, thereby increasing business for his pharmacy.

The alignment of Harshbarger's occupation and business ownership with the bill's focus on pharmaceuticals and telehealth creates a significant conflict of interest. If the findings of the study lead to more favorable conditions for telehealth prescriptions, it could enhance the profitability of Harshbarger Pharmacy, directly benefiting him financially. This direct relationship between his personal financial interests and the bill's implications raises concerns about the integrity of the legislative process and the potential for self-serving motivations in policy-making.

Unlike federal analysis based on campaign donations, state analysis examines legislators' personal financial interests — their jobs, businesses, and investments.

Items marked "AI-researched" are generated from public sources but have not been independently verified. Verified data is sourced from official legislature websites and disclosure filings.